Chembio Diagnostics Receives FDA Emergency Use Authorization for the First Rapid Zika IgM Test
Sep 28, 2017 12:50 pm UTC| Business
MEDFORD, N.Y., Sept. 28, 2017 -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has received U.S. Food and Drug Administration...
Cora Systems Named Finalist in 2017 Pharma Industry Awards
Sep 28, 2017 12:46 pm UTC| Business
TYSONS, Va. and CARRICK ON SHANNON, Ireland, Sept. 28, 2017 -- Cora Systems, a leading global provider of enterprise portfolio, program and project management (EPPM) solutions, has been named a finalist in the 2017...
ASSIA’s CloudCheck® Mobile APP for Service Providers
Sep 28, 2017 12:45 pm UTC| Business
REDWOOD CITY, Calif., Sept. 28, 2017 -- Adaptive Spectrum and Signal Alignment, Inc. (ASSIA®). ASSIA, the market leader in software solutions that deliver reliable fast broadband and optimized Wi-Fi to the home,...
Modern Cinema Group Inc. Announces Patent Application Filed for Media Futures Exchange
Sep 28, 2017 12:43 pm UTC| Business
Beverly Hills, California , Sept. 28, 2017 -- Modern Cinema Group Inc. (OTCPK: MOCI) is proud to announce the filing of a novel patent application esigned to solve problems relating to the financing, distribution and...
Abeona Therapeutics and Brammer Bio Announce Collaboration for Commercial Translation of ABO-102
Sep 28, 2017 12:32 pm UTC| Business
--Strategic alignment with Brammer Bio for commercial AAV process development, scale up and assay validation --Phillip B. Maples, Ph.D., to lead Abeona manufacturing, as VP of Therapeutics Development and Quality...
Auris Medical Announces Transfer to Nasdaq Capital Market
Sep 28, 2017 12:31 pm UTC| Business
Zug, Switzerland, September 28, 2017 - Auris Medical Holding AG (the "Company", NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology,...
Sep 28, 2017 12:30 pm UTC| Business
CAMBRIDGE, Mass., Sept. 28, 2017 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare...